Reply: To PMID 22967868.
作者信息
Cheng Sheng-Fu, Dastjerdi Mohammad H, Ferrari Giulio, Okanobo Andre, Amparo Francisco, Stevenson William, Hamrah Pedram, Nallasamy Nambi, Dana Reza, Bower Kraig S, Ryan Denise S
出版信息
Am J Ophthalmol. 2013 Jul;156(1):204-5. doi: 10.1016/j.ajo.2013.03.018.
Abstract
摘要
相似文献
1
Reply: To PMID 22967868.
Am J Ophthalmol. 2013 Jul;156(1):204-5. doi: 10.1016/j.ajo.2013.03.018.
2
Deep intrastromal injection of bevacizumab for the management of corneal neovascularization.
Cornea. 2013 Jan;32(1):109-10. doi: 10.1097/ICO.0b013e318262e872.
3
Short-term topical bevacizumab in the treatment of stable corneal neovascularization.
Am J Ophthalmol. 2013 Jul;156(1):204. doi: 10.1016/j.ajo.2013.03.014.
4
The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization.
Acta Ophthalmol. 2013 May;91(3):e246-8. doi: 10.1111/j.1755-3768.2012.02540.x. Epub 2012 Sep 23.
5
Intrastromal injection of bevacizumab in patients with corneal neovascularization.
Arq Bras Oftalmol. 2012 Jul-Aug;75(4):277-9. doi: 10.1590/s0004-27492012000400012.
6
Reply: To PMID 23377751.
Cornea. 2013 Dec;32(12):e193-4. doi: 10.1097/ICO.0b013e3182a9e74d.
7
Bilateral response after unilateral subconjunctival bevacizumab injection in a child with Stevens-Johnson syndrome.
J AAPOS. 2012 Jun;16(3):309-11. doi: 10.1016/j.jaapos.2011.12.153. Epub 2012 Mar 28.
8
Bevacizumab for corneal neovascularization.
Ophthalmology. 2009 Mar;116(3):592-3; author reply 593-4. doi: 10.1016/j.ophtha.2008.10.011.
9
[Bevacizumab goes anterior: antiangiogenic therapy at cornea and conjunctiva].
Ophthalmologe. 2009 May;106(5):397-8. doi: 10.1007/s00347-009-1933-1.
10
[Subconjunctival injection of bevacizumab for treatment of corneal neovascularization after perforating keratoplasty].
Klin Monbl Augenheilkd. 2009 Jul;226(7):573-5. doi: 10.1055/s-0028-1109496. Epub 2009 Jul 30.
Zotero 插件